RZLT Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-28 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 1,076 | P-Purchase | A | 500 | 2.55 | 1,275.00 |
| 2022-07-22 | HANDOK, INC. | director, 10 percent owner: | 5,942,617 | P-Purchase | A | 3,157,895 | 3.80 | 12,000,001.00 |
| 2021-10-15 | HANDOK, INC. | director, 10 percent owner: | 2,784,722 | P-Purchase | A | 769,231 | 6.50 | 5,000,002.00 |
| 2024-03-15 | Evans Daron | officer: CFO | 20,000 | P-Purchase | A | 20,000 | 1.69 | 33,830.00 |
| 2024-03-14 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 10,000 | P-Purchase | A | 10,000 | 1.88 | 18,800.00 |
| 2024-03-07 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 576 | P-Purchase | A | 500 | 1.85 | 925.00 |
| 2024-03-07 | Kim Young-Jin | director | 115,450 | P-Purchase | A | 36,503 | 1.91 | 69,859.00 |
| 2022-07-22 | Kim Young-Jin | director | 78,947 | P-Purchase | A | 78,947 | 3.80 | 299,999.00 |
| 2024-03-07 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 500 | P-Purchase | A | 500 | 1.85 | 925.00 |
| 2024-03-08 | Evans Daron | officer: CFO | 120,900 | P-Purchase | A | 50,000 | 1.93 | 96,345.00 |
| 2024-02-26 | Elam Nevan C | director, officer: CEO | 7,817 | P-Purchase | A | 5,000 | 1.68 | 8,400.00 |
| 2024-02-26 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 42,552 | P-Purchase | A | 2,000 | 1.70 | 3,400.00 |
| 2024-02-23 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 40,552 | P-Purchase | A | 6,000 | 1.69 | 10,140.00 |
| 2024-02-16 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 34,552 | P-Purchase | A | 7,000 | 1.31 | 9,142.00 |
| 2024-02-16 | Evans Daron | officer: CFO | 70,900 | P-Purchase | A | 41,900 | 1.30 | 54,411.00 |
| 2024-02-16 | Evans Daron | officer: CFO | 4,500 | P-Purchase | A | 4,500 | 1.37 | 6,165.00 |
| 2024-01-23 | Evans Daron | officer: CFO | 275,000 | A-Award | A | 275,000 | 1.02 | 280,500.00 |
| 2024-01-22 | Evans Daron | officer: CFO | 29,000 | D | 0 | 0.00 | 0.00 | |
| 2024-01-22 | Evans Daron | officer: CFO | 10,000 | I | 0 | 0.00 | 0.00 | |
| 2024-01-23 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 130,000 | A-Award | A | 130,000 | 1.02 | 132,600.00 |
| 2024-01-23 | Elam Nevan C | director, officer: CEO | 340,000 | A-Award | A | 340,000 | 1.02 | 346,800.00 |
| 2024-01-23 | Hogenhuis Wladimir | director | 30,000 | A-Award | A | 30,000 | 1.02 | 30,600.00 |
| 2024-01-23 | Labrucherie Gil M | director | 30,000 | A-Award | A | 30,000 | 1.02 | 30,600.00 |
| 2024-01-23 | FAUCHET PHILIPPE | director | 30,000 | A-Award | A | 30,000 | 1.02 | 30,600.00 |
| 2024-01-23 | KREHER NERISSA | director | 30,000 | A-Award | A | 30,000 | 1.02 | 30,600.00 |
| 2023-07-03 | ROBERTS BRIAN KENNETH | officer: Chief Medical Officer | 27,552 | P-Purchase | A | 5,000 | 1.90 | 9,500.00 |
| 2022-06-23 | Kim Young-Jin | director: | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-06-23 | FAUCHET PHILIPPE | director: | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2022-06-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 700,000 | A-Award | A | 700,000 | 0.00 | 0.00 |
| 2022-06-23 | Hogenhuis Wladimir | director: | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2022-06-23 | Hogenhuis Wladimir | director | 80,000 | A-Award | A | 80,000 | 3.40 | 272,000.00 |
| 2022-06-23 | Elam Nevan C | officer: Chief Executive Officer | 2,600,000 | A-Award | A | 2,600,000 | 0.00 | 0.00 |
| 2022-06-23 | Elam Nevan C | director, officer: Chief Executive Officer | 2,600,000 | A-Award | A | 2,600,000 | 3.40 | 8,840,000.00 |
| 2022-06-23 | Labrucherie Gil M | director: | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2022-06-23 | Labrucherie Gil M | director | 80,000 | A-Award | A | 80,000 | 3.40 | 272,000.00 |
| 2022-06-23 | KREHER NERISSA | director: | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2022-05-17 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 22,552 | P-Purchase | A | 300 | 2.95 | 883.80 |
| 2022-05-04 | Labrucherie Gil M | director | 53,572 | P-Purchase | A | 52,631 | 3.80 | 199,998.00 |
| 2022-05-04 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 21,052 | P-Purchase | A | 21,052 | 3.80 | 79,998.00 |
| 2022-05-04 | Labrucherie Gil M | director: | 52,631 | P-Purchase | A | 52,631 | 3.80 | 199,998.00 |
| 2022-05-04 | Hogenhuis Wladimir | director | 32,693 | P-Purchase | A | 25,000 | 3.80 | 95,000.00 |
| 2021-10-15 | Hogenhuis Wladimir | director | 7,693 | P-Purchase | A | 7,693 | 6.50 | 50,004.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 675,000 | A-Award | A | 375,000 | 12.28 | 4,605,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 575,000 | D-Return | D | 100,000 | 14.50 | 1,450,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 0 | D-Return | D | 70,000 | 60.00 | 4,200,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 0 | D-Return | D | 34,800 | 103.00 | 3,584,400.00 |
| 2019-07-23 | Genexine Inc. | 10 percent owner | 91,300,933 | P-Purchase | A | 34,482,758 | 0.29 | 10,000,000.00 |
| 2019-04-26 | Genexine Inc. | 10 percent owner | 56,818,175 | C-Conversion | A | 56,818,175 | 0.00 | 0.00 |
| 2019-04-26 | Genexine Inc. | 10 percent owner | 0 | C-Conversion | D | 1,250,000 | 0.22 | 275,000.00 |
| 2019-01-30 | Genexine Inc. | 10 percent owner | 0 | D | 56,818,175 | 0.22 | 12,499,998.00 | |
| 2021-06-14 | Hogenhuis Wladimir | director | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2021-06-14 | Hogenhuis Wladimir | director | 10,000 | A-Award | A | 10,000 | 12.28 | 122,800.00 |
| 2021-06-14 | FAUCHET PHILIPPE | director | 2,000 | A-Award | A | 2,000 | 12.28 | 24,560.00 |
| 2021-06-14 | KREHER NERISSA | director | 10,000 | A-Award | A | 10,000 | 12.28 | 122,800.00 |
| 2021-06-14 | Labrucherie Gil M | director | 5,000 | A-Award | A | 5,000 | 12.28 | 61,400.00 |
| 2021-06-14 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 75,000 | A-Award | A | 75,000 | 12.28 | 921,000.00 |
| 2021-06-14 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D-Return | D | 9,000 | 52.50 | 472,500.00 |
| 2021-06-14 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D-Return | D | 20,000 | 14.50 | 290,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 675,000 | A-Award | A | 375,000 | 12.28 | 4,605,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 575,000 | D-Return | D | 100,000 | 14.50 | 1,450,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 0 | D-Return | D | 70,000 | 60.00 | 4,200,000.00 |
| 2021-06-14 | Elam Nevan C | director, officer: Chief Executive Officer | 0 | D-Return | D | 34,800 | 103.00 | 3,584,400.00 |
| 2021-03-03 | Hogenhuis Wladimir | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2021-03-03 | KREHER NERISSA | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2020-10-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D | 3,400 | 156.00 | 530,400.00 | |
| 2020-10-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D | 9,000 | 52.50 | 472,500.00 | |
| 2020-10-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D | 20,000 | 14.50 | 290,000.00 | |
| 2020-10-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D | 3,400 | 156.00 | 530,400.00 | |
| 2020-10-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D | 9,000 | 52.50 | 472,500.00 | |
| 2020-10-23 | ROBERTS BRIAN KENNETH | officer: Sr VP, Clinic Development | 0 | D | 20,000 | 14.50 | 290,000.00 | |
| 2020-10-12 | HANDOK, INC. | 10 percent owner | 100,649,528 | P-Purchase | A | 125,000 | 0.46 | 58,112.00 |
| 2020-10-13 | HANDOK, INC. | 10 percent owner | 2,015,491 | P-Purchase | A | 2,500 | 23.35 | 58,380.00 |
| 2020-10-07 | HANDOK, INC. | 10 percent owner | 100,524,528 | P-Purchase | A | 125,000 | 0.41 | 50,925.00 |
| 2020-10-06 | HANDOK, INC. | 10 percent owner | 100,399,528 | P-Purchase | A | 125,000 | 0.42 | 52,900.00 |
| 2020-10-06 | HANDOK, INC. | director | 100,399,528 | P-Purchase | A | 125,000 | 0.42 | 52,900.00 |
| 2020-10-05 | HANDOK, INC. | 10 percent owner | 100,274,528 | P-Purchase | A | 125,000 | 0.46 | 57,175.00 |
| 2020-10-05 | HANDOK, INC. | director | 100,274,528 | P-Purchase | A | 125,000 | 0.46 | 57,175.00 |
| 2020-10-02 | HANDOK, INC. | 10 percent owner | 100,149,528 | P-Purchase | A | 125,000 | 0.45 | 56,362.00 |
| 2020-10-01 | HANDOK, INC. | 10 percent owner | 100,024,528 | P-Purchase | A | 125,000 | 0.44 | 55,038.00 |
| 2020-09-30 | HANDOK, INC. | 10 percent owner | 99,899,528 | P-Purchase | A | 125,000 | 0.44 | 54,538.00 |
| 2020-09-29 | HANDOK, INC. | 10 percent owner | 99,774,528 | P-Purchase | A | 125,000 | 0.45 | 55,688.00 |
| 2020-09-28 | HANDOK, INC. | 10 percent owner | 99,649,528 | P-Purchase | A | 125,000 | 0.44 | 55,475.00 |
| 2020-09-25 | HANDOK, INC. | 10 percent owner | 99,524,528 | P-Purchase | A | 125,000 | 0.45 | 55,738.00 |
| 2020-09-24 | HANDOK, INC. | 10 percent owner | 99,399,528 | P-Purchase | A | 125,000 | 0.44 | 55,400.00 |
| 2020-09-23 | HANDOK, INC. | 10 percent owner | 99,274,528 | P-Purchase | A | 125,000 | 0.46 | 57,138.00 |
| 2020-09-22 | HANDOK, INC. | 10 percent owner | 99,149,528 | P-Purchase | A | 125,000 | 0.46 | 57,362.00 |
| 2020-09-21 | HANDOK, INC. | 10 percent owner | 99,024,528 | P-Purchase | A | 125,000 | 0.46 | 57,362.00 |
| 2020-09-18 | HANDOK, INC. | 10 percent owner | 98,899,528 | P-Purchase | A | 125,000 | 0.46 | 57,562.00 |
| 2020-09-17 | HANDOK, INC. | 10 percent owner | 98,774,528 | P-Purchase | A | 125,000 | 0.46 | 57,712.00 |
| 2020-09-16 | HANDOK, INC. | 10 percent owner | 98,649,528 | P-Purchase | A | 125,000 | 0.46 | 57,162.00 |
| 2020-09-10 | FAUCHET PHILIPPE | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2020-09-15 | HANDOK, INC. | 10 percent owner | 98,524,528 | P-Purchase | A | 125,000 | 0.45 | 56,412.00 |
| 2020-09-14 | HANDOK, INC. | 10 percent owner | 98,399,528 | P-Purchase | A | 125,000 | 0.46 | 57,550.00 |
| 2020-09-11 | HANDOK, INC. | 10 percent owner | 98,274,528 | P-Purchase | A | 125,000 | 0.49 | 61,350.00 |
| 2020-09-10 | HANDOK, INC. | 10 percent owner | 98,149,528 | P-Purchase | A | 125,000 | 0.49 | 61,225.00 |
| 2020-09-09 | HANDOK, INC. | 10 percent owner | 98,024,528 | P-Purchase | A | 125,000 | 0.49 | 61,150.00 |
| 2020-09-08 | HANDOK, INC. | 10 percent owner | 97,899,528 | P-Purchase | A | 125,000 | 0.45 | 55,975.00 |
| 2020-09-04 | HANDOK, INC. | 10 percent owner | 97,774,528 | P-Purchase | A | 125,000 | 0.48 | 60,400.00 |
| 2020-09-03 | HANDOK, INC. | 10 percent owner | 97,649,528 | P-Purchase | A | 125,000 | 0.49 | 60,725.00 |
| 2020-09-02 | HANDOK, INC. | 10 percent owner | 97,524,528 | P-Purchase | A | 125,000 | 0.58 | 72,688.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
